$371 Million is the total value of Foresite Capital Management IV, LLC's 8 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 11.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KNTE | Kinnate Biopharma Inc. | $121,959,000 | +12.0% | 9,671,643 | 0.0% | 32.84% | +7.8% | |
| LYEL | Lyell Immunopharma, Inc. | $86,600,000 | +29.1% | 13,282,181 | 0.0% | 23.32% | +24.3% | |
| PHVS | Sell | Pharvaris N.V. | $71,757,000 | +21.3% | 3,246,926 | -0.5% | 19.32% | +16.8% |
| ACRS | Sell | Aclaris Therapeutics, Inc. | $39,200,000 | -21.6% | 2,808,034 | -3.1% | 10.56% | -24.5% |
| KURA | Kura Oncology, Inc. | $33,910,000 | +14.0% | 1,849,947 | 0.0% | 9.13% | +9.7% | |
| NRIX | Sell | Nurix Therapeutics, Inc. | $8,579,000 | -40.6% | 677,143 | -34.3% | 2.31% | -42.8% |
| CBAY | Cymabay Therapeutics, Inc. | $5,272,000 | -5.1% | 1,787,094 | 0.0% | 1.42% | -8.7% | |
| QSI | Sell | Quantum-Si Incorporated | $4,109,000 | -80.3% | 1,771,249 | -60.3% | 1.11% | -81.1% |
| Exit | Cue Health Inc. | $0 | – | -263,578 | -100.0% | -0.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CymaBay Therapeutics, Inc. | 23 | Q3 2023 | 14.8% |
| Aclaris Therapeutics, Inc. | 18 | Q3 2023 | 18.9% |
| Kura Oncology, Inc. | 16 | Q3 2023 | 11.7% |
| Kinnate Biopharma Inc. | 12 | Q3 2023 | 41.8% |
| Myokardia, Inc. | 12 | Q3 2020 | 17.8% |
| Pharvaris N.V. | 11 | Q3 2023 | 43.4% |
| Cytokinetics Incorporated | 11 | Q2 2021 | 31.6% |
| Lyell Immunopharma, Inc. | 10 | Q3 2023 | 29.2% |
| Insmed Incorporated | 10 | Q1 2020 | 19.2% |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | Q1 2020 | 14.5% |
View Foresite Capital Management IV, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-05 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 4 | 2023-05-10 |
| 4 | 2023-02-22 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
View Foresite Capital Management IV, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.